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Myo5b knockout mice as a model 
of microvillus inclusion disease
Fernando Cartón-García1,2, Arend W. Overeem3, Rocio Nieto1,2, Sarah Bazzocco1,2, 
Higinio Dopeso1,2, Irati Macaya1,2, Josipa Bilic1,2, Stefania Landolfi4, Javier Hernandez-Losa4, 
Simo Schwartz Jr5, Santiago Ramon y Cajal4, Sven C. D. van Ijzendoorn3 & Diego Arango1,2
Inherited MYO5B mutations have recently been associated with microvillus inclusion disease (MVID), 
an autosomal recessive syndrome characterized by intractable, life-threatening, watery diarrhea 
appearing shortly after birth. Characterization of the molecular mechanisms underlying this disease 
and development of novel therapeutic approaches is hampered by the lack of animal models. In 
this study we describe the phenotype of a novel mouse model with targeted inactivation of Myo5b. 
Myo5b knockout mice show perinatal mortality, diarrhea and the characteristic mislocalization of 
apical and basolateral plasma membrane markers in enterocytes. Moreover, in transmission electron 
preparations, we observed microvillus atrophy and the presence of microvillus inclusion bodies. 
Importantly, Myo5b knockout embryos at day 20 of gestation already display all these structural 
defects, indicating that they are tissue autonomous rather than secondary to environmental cues, 
such as the long-term absence of nutrients in the intestine. Myo5b knockout mice closely resemble 
the phenotype of MVID patients and constitute a useful model to further investigate the underlying 
molecular mechanism of this disease and to preclinically assess the efficacy of novel therapeutic 
approaches.
Microvillus inclusion disease (MVID) is an autosomal recessive syndrome affecting the intestinal epithe-
lium1,2. It was first described in 1978 and it is characterized by the onset of abundant neonatal watery 
diarrhea that most commonly starts within the first days of life, and can cause the loss of up to 30% of 
body weight within 24 h1,2. In some cases (<20%), MVID manifests at later times, within the first 3–4 
months of life.
The diagnosis of MVID is based on the detection of morphological abnormalities in the intesti-
nal epithelium using a combination of light and electron microscopy. Histological examination of the 
small intestinal mucosa reveals a variable degree of villus atrophy. In addition, there is a characteristic 
accumulation of periodic acid–Schiff (PAS)-positive cytoplasmic granules in intestinal epithelial cells3,4. 
Transmission electron microscopy (TEM) of intestinal epithelial biopsies is used to confirm the diag-
nosis. Ultrastructural defects in small intestinal enterocytes include the shortening of microvilli and the 
presence of distinctive cytoplasmic vacuoles lined by microvilli, known as microvillus inclusion bodies5.
Inactivating mutations in MYO5B have recently been associated with the majority of cases of MVID6,7. 
MYO5B codes for the unconventional myosin Vb, an actin-based motor involved in plasma membrane 
recycling through its interactions with RAB GTPases8. The loss of a functional Myosin Vb protein results 
in profound protein trafficking defects in enterocytes leading to the mistargeting of apical and basolateral 
proteins9,10. These abnormalities in the structure of the apical brush border and the mislocalization of 
membrane proteins are likely responsible for the absorption defects and the watery diarrhea observed in 
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these patients, but the detailed molecular mechanisms remain to be fully elucidated. Currently, the only 
treatment options available for this uniformly fatal disease are total parenteral nutrition and intestinal 
transplant11.
Here we describe the phenotype of the first animal model with targeted inactivation of Myo5b. Mice 
deficient for this myosin show perinatal mortality, watery diarrhea and the characteristic structural 
defects of patients with MVID. This study provides formal demonstration of MYO5B mutations as the 
cause of microvillus inclusion disease. Moreover, the availability of this mouse model will decisively con-
tribute to shed new light on the underlying molecular mechanisms of this disease and the development 
and testing of new therapeutic approaches for MVID patients.
Results
Survival of Myo5b knockout mice. Homologous recombination was used to introduce a targeting 
cassette including the mouse En2 splice acceptor and the SV40 polyadenylation sequences after exon 
4 of Myo5b, which is predicted to generate a null allele through splicing to a lacZ “gene trap” element 
(Supplementary Figure 1)12. As expected, mice homozygous for the trapped allele showed no Myosin Vb 
expression in their intestine (henceforth referred to as Myo5b knockout mice; Fig. 1). Wild type, hete-
rozygous or Myo5b knockout embryos at day 20 of gestation (E20) showed no difference in their size or 
weight (Fig. 2A,B). Animals were born at Mendelian ratios (n = 99; Chi-square test, p = 0.14; Fig. 2C), 
but Myo5b knockout mice invariably died within the first 12 h after being born (Fig. 2D). No differences 
were observed between wild type and knockout newborn mice in their body size (Fig. 2E) or the gross 
histology of the gastrointestinal tract (Supplementary Figure 2) or other organs studied, including the 
lungs, liver, central nervous system, heart, pancreas and spleen. No cyanotic episodes or respiratory dis-
tress was observed in Myo5b knockout mice. However, newborn Myo5b knockout mice showed reduced 
bodyweight compared to wild type and heterozygous mice (Fig. 2F). Moreover, knockout mice showed 
signs of diarrhea and wrinkled skin, possibly due to dehydration (Fig. 2G,H). Although newborn Myo5b 
knockout mice showed no suckling defects (presence of a milk spot; Fig. 2G,H), they had significantly 
reduced blood glucose levels compared to wild type and heterozygous littermates (Fig. 2I). This is con-
sistent with the watery diarrhea and absorption defects observed in patients with MVID1,2 and likely 
contributed to the death of the Myo5b knockout mice within hours of birth13.
Mislocalization of apical brush border proteins in the enterocytes of Myo5b knockout mice. 
At the ultrastructural level, the intestinal enterocytes of Myo5b knockout newborn mice showed the char-
acteristic cytoplasmic accumulation of periodic-acid Schiff (PAS) staining observed in MVID patients3,4 
(Fig.  3A,B). Moreover, proteins normally expressed in the apical membrane of intestinal enterocytes 
such as alkaline phosphatase (ALP; Fig. 3C,D), 5’-Nucleotidase (5’NT; Fig. 3E,F) and ezrin (Fig. 3G,H) 
mislocalized to the basolateral membrane or the cytoplasm. Transferrin receptor (TfR) accumulated in 
the basal cytoplasm of enterocytes from Myo5b knockout mice (Fig. 3I,J), while other basolateral markers 
such as E-cadherin (Fig. 3K,L) and β -catenin (Fig. 3M,N) were unaffected. Notably, in some epithelial 
cells of Myo5b knockout mice ezrin (Fig. 3G,H) and actin (Fig. 3O,P) were found in circular cytoplas-
mic structures, closely resembling microvillus inclusions. These findings are in good agreement with the 
protein sorting defects observed in the intestinal epithelium of patients with MVID3,6,14,15. Importantly, 
these structural defects were also observed in E20 embryos (Supplementary Figure 3A–L).
Ultrastructural defects in the brush border of the enterocytes of Myo5b knockout mice. 
Transmission electron microscopy (TEM) analysis of the intestinal epithelium revealed the presence of 
microvillus inclusion bodies in the cytoplasm of absorptive cells from Myo5b knockout E20 embryos 
(Fig. 4A). In addition, the apical surface of the intestinal enterocytes showed widespread microvilli atro-
phy and reduced packing with areas with few/absent microvilli (Fig. 4B–D and Supplementary Figure 4) 
and presence of microvilli in the lateral plasma membrane (Fig. 4E,F). Vesicles were frequently observed 
at the apical plasma membrane in Myo5b wild type mice but not in the Myo5b knockout animals, where 
a characteristic accumulation of vesicles could be observed underneath the terminal web (Fig.  4B and 
Supplementary Figure 4). These ultrastructural abnormalities closely resemble the phenotype observed 
in the intestinal epithelium of patients with MVID (Fig. 5A–C)4,5.
Discussion
We describe here the phenotype of the first mouse model with targeted inactivation of Myo5b. Germline 
mutations in this gene are associated with microvillus inclusion disease (MVID)6, a congenital dis-
order of the intestinal epithelium causing persistent life-threatening watery diarrhea1,2. Myosin Vb is 
an actin-based molecular motor with a key role in vesicle trafficking and plasma membrane recycling 
through its interaction with the small GTPases RAB11 and RAB88,9. It is not surprising, therefore, 
that inactivation of either Rab11a or Rab8a in the mouse intestine resulted in nutrient malabsorption, 
intracellular accumulation of apical proteins in intestinal epithelial cells, shortening of microvilli and 
microvillus inclusion bodies16,17. Interestingly, inactivation of the small GTPase Cdc42 also caused micro-
villi shortening and microvillus inclusions in intestinal epithelial cells18. However, diarrhea, one of the 
hallmarks of MVID patients, was not observed in Rab11 or Cdc42 knockout mice17,18, and Rab8 knock 
out mice survived for approximately 5 weeks after birth, more closely resembling the phenotype of late 
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onset MVID. Importantly, no mutations in RAB8 or RAB11 GTPases have been identified in MYO5B 
mutation negative MVID patients19, suggesting that Myo5b deficient mice represent the optimal animal 
model for human microvillus inclusion disease.
Indeed, Myo5b knockout mice showed all the typical features observed in patients with early onset 
MVID, the most common form of this disease accounting for >80% of the cases4. Myo5b deficient mice 
showed no overt defects during embryonic development, having normal size and weight. However, new-
born Myo5b knockout mice showed watery diarrhea and died during the first 12 h of life, likely due to 
dehydration and/or reduced nutrient availability secondary to absorption defects, as exemplified by the 
low blood glucose levels observed, although the contribution of each of these symptoms to the death of 
Myo5b deficient mice cannot be conclusively determined. The body weight reduction observed in Myo5b 
knockout mice (8% in approximately 6 h) is consistent with the fluid loss reported in early onset MVID 
patients (>30% of body weight in 24 h; i.e., 7.5% in 6 h)3. In previous studies, the perinatal mortality 
of Klf4 or Scd2 newborn knockout mice was attributed to a 5–10% reduction of body weight due to 
transepidermal water loss20,21. In humans, this rapid rate of dehydration would result in hypovolemic 
shock leading to death, as observed in Myo5b knockout mice. On the other hand, newborn mice have 
Figure 1. Effects of Myo5b inactivation. Immunostaining showing Myosin Vb levels in the small (A,B) 
and large (C,D) intestine of Myo5b wild type (A and C) and knockout (B and D) newborn mice. Scale bar: 
50 μ m.
www.nature.com/scientificreports/
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previously been shown to go through a transitory phase of severe hypoglycemia (about 10 mg/dL within 
2 h of birth) until glucose levels are restored due to gluconeogenesis and eventually nutrient absorption of 
maternal milk13,22,23. Consistent with the phenotype observed in Myo5b knockout animals, the incapacity 
Figure 2. Phenotype of Myo5b E20 embryos and newborn mice. Size (A) and weight (B) of E20 embryos 
by Myo5b genotype. The mean ± SEM is shown. N = number of animals per group. (C) Genotype of 99 mice 
born from crossing heterozygous male and female mice. (D) Percentage of these 99 mice that were alive 12 h 
after birth. Size (E) and weight (F) of newborn mice by Myo5b genotype (mean ± SEM). Newborn wild 
type (G) and Myo5b knockout (H) mice showing the presence of the milk spot (white arrowhead), wrinkled 
skin (black arrowhead) and evidence of diarrhea (arrow). (I) Histogram showing average (± SEM) blood 
glucose levels in Myo5b wild type, heterozygous and newborn mice. *p < 0.05; ***p < 0.001 (Student’s T-test).
www.nature.com/scientificreports/
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Figure 3. Changes in the localization of apical and basolateral protein markers in Myo5b knockout 
newborn mice. Periodic acid–Schiff (PAS) staining (A,B), alkaline phosphatase (ALP) staining (C,D; 
arrowheads indicate the subapical accumulation of ALP in Myo5b knockout mice), immunostaining of 
5’-Nucleotidase (5’NT; E,F; arrowheads indicate the apical distribution of 5’NT in wild type mice), ezrin 
(G,H; arrowhead indicates an intracellular ezrin-coated vesicle in Myo5b knockout mice), transferrin 
receptor (TfR; I,J; arrowheads indicate the basal accumulation of TfR in Myo5b knockout mice), E-Cadherin 
(K,L), β -catenin (M,N) and actin (O,P; arrowheads indicate intracellular actin-coated vesicles in Myo5b 
knockout mice) in Myo5b wild type and knockout newborn mice. Scale bar: 25 μ m.
www.nature.com/scientificreports/
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Figure 4. Ultrastructural defects in the intestinal epithelium of knockout Myo5b E20 embryos.  
(A) TEM micrograph showing microvillus inclusion bodies in Myo5b knockout E20 embryos (scale bar 
0.5 μ m). (B) Apical microvilli of enterocytes in Myo5b wild type and knockout E20 embryos (scale bar 0.5 μ m). 
MV: microvilli; White arrowheads: subapical microvesicles; asterisk indicates a subapical region devoid of 
microvesicles. (C) Average (± SEM) length of microvilli projecting into the lumen and actin rootlets. (D) 
Number of microvilli observed per micrometer in transverse sections of the brush border. The normal junction 
between enterocytes in wild type Myo5b E20 embryos is shown in (E). Scale bar 1 μ m. Microvilli-like structures 
could be observed in the lateral membrane of enterocytes in Myo5b knockout mice (F). Scale bar 1 μ m. 
**p < 0.01 (Student’s T-test).
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of newborn mice to overcome the postnatal hypoglycemia has been shown to be fatal within 18 h22. 
Moreover, although no reproducible defects have been reported in other organs of MVID patients and 
no histological abnormalities were observed in the Myo5b knockout mice, additional studies of the func-
tion of other organs and the possible contribution to the death of Myo5b deficient mice are warranted.
Consistent with the changes observed in the intestinal epithelium of MVID patients1,2, important 
structural defects were observed in the enterocytes of Myo5b knockout newborn mice, including the 
mislocalization of apical and basolateral markers, microvillus atrophy and the presence of microvillus 
inclusion bodies. Collectively, this study provides formal demonstration of the inactivation of Myo5b as 
the cause of microvillus inclusion disease. Moreover, these results indicate that the absence of a func-
tional Myosin Vb protein, rather than the presence of pathogenic Myosin Vb mutations24, is responsible 
for the intestinal defects observed in MVID patients. In addition, the presence of ultrastructural defects 
in the enterocytes of Myo5b-deficient E20 embryos indicates that this phenotype is tissue-autonomous. 
However, the characteristic villus atrophy observed in patients with MVID was not observed in Myo5b 
knockout E20 embryos or newborn mice (Supplementary Figure 2E), suggesting that this phenotype is 
secondary to environmental cues, such as the prolonged absence of nutrients in their gastrointestinal 
tract25. The Myo5b knockout model described here will be instrumental for the characterization of the 
molecular mechanisms downstream of Myosin Vb responsible for the phenotype observed in patients 
with MVID, and should significantly contribute to the identification of novel therapeutic approaches for 
these patients.
It has been reported that up to 75% of MVID patients die before 9 months of age4. Different pharma-
cological approaches have been used in an attempt to stop/reduce the severe diarrhea in these patients, 
but none of them has proven effective4. Patients are dependent on total parenteral nutrition, which over 
time often causes liver damage and sepsis. Small-bowel transplantation is the only option available to 
Figure 5. Ultrastructural defects in the intestinal epithelium of MVID patients. (A) Transmission 
electron microscopy pictures from a duodenum biopsy of a MVID patient carrying a homozygous MYO5B 
nonsense mutation (c.4366C > T, p.1456X). (B) Larger magnification of a region containing lateral 
microvilli-like structures (white arrowheads). (C) Detail of the apical region containing short/poorly packed 
microvilli (MV) and a subapical area devoid of microvesicles (asterisk).
www.nature.com/scientificreports/
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avoid parenteral nutrition and improve the quality of life and the long-term prognosis of these children11. 
However, intestinal transplantation is associated with high rates of rejection and/or mortality11, and addi-
tional therapeutic options are urgently needed for these patients. The Myo5b knockout model described 
here will constitute an ideal system to preclinically test the efficiency of possible new treatment options, 
including pharmacological or gene therapy using for example autologous reimplantation of intestinal 
epithelium grown ex vivo following restoration of functional Myosin Vb26.
In conclusion, we describe here the phenotype of Myo5b knockout mice, which closely phenocop-
ies human early-onset microvillus inclusion disease. These experiments confirm the important role of 
Myosin Vb in the formation of the apical brush border and the sorting of apical and basolateral proteins 
in intestinal absorptive cells, and formally demonstrate that the loss of a functional Myosin Vb protein is 
responsible for the phenotype observed in MVID patients. The availability of this mouse model of MVID 
will not only contribute to the characterization of the molecular pathological mechanisms downstream 
of Myosin Vb leading to novel therapeutic approaches, but also provides an ideal system to preclinically 
test different treatment options.
Methods
Generation of Myo5b knockout mice. Myo5btm1a(KOMP)Wtsi targeted ES cells (C57BL/6N, agouti) 
were obtained from the KOMP repository at UC Davis12,27. After expansion, cells were injected into 
donor blastocysts and transplanted into pseudopregnant females. Chimeric male offspring were mated 
to C57BL/6N females to confirm germ line transmission. Animals were genotyped by PCR. The prim-
ers used were: Myo5b-F: 5’-CCA GTT CCT TGG GGA CAT AA-3’, loxP-F: 5’-GAG ATG GCG CAA 
CGC AAT TAA TG-3’ and Myo5b-R: 5’-AGT GAT GCT GTC CTG AGT GTA CTG G-3’. The initial 
tm1a allele generates a null allele through splicing to a lacZ trapping element, including the mouse 
En2 splice acceptor and the SV40 polyadenylation sequences (Supplementary Figure 1). Heterozygous 
Myo5btm1a(KOMP)Wtsi mice were intercrossed to obtain animals homozygous for the targeted Myo5b allele 
(knockout mice). All animal experiments were carried out according to procedures approved by the 
Ethics Committee for Animal Experimentation at Vall d´Hebron Research Institute.
Transmission electron microscopy. Duodenal samples were collected from Myo5b wild type and 
Myo5b knockout E20 embryos (at least 3 animals per genotype). Samples were fixed with 2.5% glu-
taraldehyde and 2% paraformaldehyde and processed following standard procedures. Ultra-thin sec-
tions were mounted on copper grids, contrasted with uranyle acetate/lead citrate double-staining, and 
observed in a Jeol JEM-1400 (Jeol LTD, Tokyo, Japan) transmission electron microscope equipped with 
a Gatan Ultrascan ES1000 CCD camera. The brush border architecture was evaluated on a minimum of 
12 enterocytes per animal. Microvilli length (actin rootlet and actin core bundles) and microvilli density 
(microvilli/μ m) were measured using ImageJ software. Duodenum biopsy sample from a MVID patient 
carrying a homozygous MYO5B nonsense mutation (c.4366C > T, p.1456X) was obtained after removal 
of the diseased intestine during the transplantation procedure10. The sample was fixed in 2% glutaral-
dehyde in phosphate buffer, rinsed in 6.8% sucrose in phosphate buffer, and postfixed in a solution of 
1% osmium tetroxide in 0.1 mol/L sodium cacodylate buffer containing 11.2% potassium ferrocyanide. 
Samples were dehydrated with ethanol and processed according to standard procedures upon embed-
ding. Ultra-thin sections were mounted on copper grids and contrasted with uranyle acetate and lead 
citrate double-staining.
Histology and immunohistochemistry. Myo5b wild type and knockout embryos were obtained at 
day 20 of gestation (E20) and sacrificed by decapitation on ice-cold PBS. Newborns were collected within 
6 hours of birth, and sacrificed by decapitation. Both embryos and newborn mice were weighted and 
measured using a caliper. Blood samples were obtained form tail clips of newborn mice. Glucose levels 
were measured with a Glucocard G+ meter (Menarini diagnostics, Barcelona). The small and large intes-
tine were dissected from embryos or newborn mice, their length measured and then fixed overnight with 
4% formalin, dehydrated by serial immersion in 50%, 70%, 96%, 100% ethanol and xylene and embedded 
in paraffin. In parallel, formalin-fixed duodenal samples obtained from newborns were cryoprotected 
in 15% sucrose in PBS overnight, then 30% sucrose overnight. Samples were then immersed in OCT 
(VWR) and frozen on dry-ice for cryosectioning.
For MYO5B, E-cadherin and β -catenin immunostaining, the NovoLink polymer detection system 
(Novocastra Laboratories) was used. Inmunostaining was carried out in 3 μ m tissue sections, after dep-
araffination and antigen retrieval with 10 mM citrate buffer pH 6.0 in a pressure cooker for 4 min. The 
antibodies used were: anti-MYO5B (Atlas antibodies HPA040902; 1:800); anti-E-cadherin (BD Bioscience 
cat# 610181; 1:100) and β -catenin (BD Bioscience cat# 610154; 1:100). For Ezrin and Transferrin recep-
tor inmunostaining, epitopes were retrieved at 100 °C for 20 minutes in 10 mM citric acid, 0.05% Tween 
20 pH6.0. For 5’-nucleotidase, epitopes were retrieved with 10 mM Tris Base, 1 mM EDTA Solution, 
0.05% Tween 20, pH 9.0. Non-specific binding sites were blocked with 5% FCS and 1% BSA in PBS 
overnight. Primary antibodies were diluted in blocking solution with 0.05% Tween 20 at 37 °C for 
2 hours followed by 1 hour incubation with Alexa-Fluor-488-conjugated (Ezrin and 5’-nucleotidase) or 
Alexa-Fluor-543-conjugated secondary antibody (Transferrin receptor). Primary antibodies used were: 
anti-Ezrin (Tebu Bio, 1:100), anti-Transferrin receptor (Invitrogen, 1:100), anti-5’-nucleotidase (Abgent, 
www.nature.com/scientificreports/
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1:50). Nuclei were stained with DAPI and slides were mounted with DAKO mounting medium. For alka-
line phosphatase activity detection, slides were incubated with staining solution for a maximum of 1 h at 
37 °C. Then, counterstained with hematoxylin and washed with distillated water before mounting. Staining 
solution contains 0.4 mg/mL 5-Bromo-4-chloro-3-indolyl phosphate p-toluidine (Sigma), 0.5 mg/mL 
of nitro blue tetrazolium (Sigma), 100 mM MgCl2 (Sigma), 2 mM Levamisole hydrochloride (Santa cruz 
Biotechnology), 5 mM Sodium azide (Sigma) and 0.15 mM of 1-methoxy-5-methylphenazinium methyl 
sulphate in 100 mM Tris pH 9.5 (Sigma). Periodic acid-Schiff staining was performed after deparaffi-
nation. Briefly, the slides were immersed in 0.5% periodic acid solution (Sigma) for 5 min, washed in 
distillated water and placed in Schiff reagent (Sigma) for 15 min. Then counterstain with hematoxylin 
and mounted. For F-Actin staining, 10 μ m thick duodenal cryosections were stained with rhodamine 
phalloidin (Cytoeskeleton), nuclei were counterstained with DAPI and slides were mounted with Prolong 
antifade reagent (Invitrogen). Fluorescence microscopy pictures were taken with a confocal microscope 
(FV1000 Olympus).
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